Foresite Capital Management II as of June 30, 2020
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 3 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| 10x Genomics Class A Common (TXG) | 96.6 | $492M | 5.5M | 89.31 | |
| Epizyme | 2.7 | $14M | 862k | 16.06 | |
| Acceleron Pharma | 0.7 | $3.3M | 35k | 95.27 |
